Clinical Trial Update: Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals [EARLY_Phase 1]

View source ↗

Summary

This early-phase screening trial is evaluating prospective screening for pancreatic ductal adenocarcinoma in individuals at high risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma | EARLY_Phase 1 | Status: RECRUITING